Françoise Van Bambeke

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 54

Top Venues

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

Antibiotics (Basel, Switzerland)

Microbiology spectrum

Université catholique de Louvain, Louvain Drug Research Institute

Université Catholique de Louvain - Ecole de Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université catholique de Louvain, Louvain Drug Research Institute

Belgium

Research Director :: Louvain Drug Research Institute

Université catholique de Louvain, Louvain Drug Research Institute

Belgium

senior research associate :: Pharmacologie cellulaire et moléculaire

Université catholique de Louvain, Louvain Drug Research Institute

Belgium

research associate :: Pharmacologie cellulaire et moléculaire

Education History

Université Catholique de Louvain - Ecole de Pharmacy

Belgium

PHD

Publications

Perrin Ngougni Pokem, Xin Liu, Suzanne L Parker, Alexia Verroken, Christine Collienne, Patrice Finet, Gert-Jan Wijnant, Pierre-François Laterre, Jason Alexander Roberts, Françoise Van Bambeke, Xavier Wittebole
Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Jean-Paul Pirnay, Françoise Van Bambeke, Christine Baysse, Miguel Cámara, Sylvie Chevalier, Jean François Collet, Aurélie Crabbé, Jozef Dingemans, Alain Dufour, Linda Eeckhaudt, Alain Filloux, Olivier Lesouhaitier, Qing Wei, Daniel De Vos
In memoriam: Pierre Cornelis (1949-2023). Journal of bacteriology 206 (7) (2024)
Jean-Paul Pirnay, Françoise Van Bambeke, Christine Baysse, Miguel Cámara, Sylvie Chevalier, Jean François Collet, Aurélie Crabbé, Jozef Dingemans, Alain Dufour, Linda Eeckhaudt, Alain Filloux, Olivier Lesouhaitier, Qing Wei, Daniel De Vos
In memoriam: Pierre Cornelis (1949-2023). Journal of bacteriology 206 (7) (2024)
Perrin Ngougni Pokem, Dorian Vanneste, Stef Schouwenburg, Alan Abdulla, Matthias Gijsen, Evelyn Dhont, Dimitri van der Linden, Isabel Spriet, Pieter A J G de Cock, Birgit C P Koch, Françoise Van Bambeke, Gert-Jan Wijnant
Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy. Expert opinion on drug metabolism & toxicology (2024)
Perrin Ngougni Pokem, Xin Liu, Suzanne L Parker, Alexia Verroken, Christine Collienne, Patrice Finet, Gert-Jan Wijnant, Pierre-François Laterre, Jason Alexander Roberts, Françoise Van Bambeke, Xavier Wittebole
Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Frédéric Goormaghtigh, Françoise Van Bambeke
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance. Expert review of anti-infective therapy 22 (1-3) (2024)
Frédéric Goormaghtigh, Françoise Van Bambeke
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance. Expert review of anti-infective therapy (2024)
Gert-Jan Wijnant, Perrin Ngougni Pokem, Marie Coessens, Eleonora Cottone, Julian Ermtraud, Lieven Goeman, Steven Vervaeke, Sebastian G Wicha, Françoise Van Bambeke
Pharmacokinetics and pharmacological target attainment of standard temocillin dosing in non-critically ill patients with complicated urinary tract infections. The Journal of antimicrobial chemotherapy (2024)
Frédéric Goormaghtigh, Françoise Van Bambeke
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance. Expert review of anti-infective therapy 22 (1-3) (2024)
Wisse Van Os, Markus Zeitlinger, Anh Duc Pham, Gert-Jan Wijnant, Perrin Ngougni Pokem, Françoise Van Bambeke, Johan G C van Hasselt, Markus Zeitlinger
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections. The Journal of antimicrobial chemotherapy (2024)
Gert-Jan Wijnant, Perrin Ngougni Pokem, Marie Coessens, Eleonora Cottone, Julian Ermtraud, Lieven Goeman, Steven Vervaeke, Sebastian G Wicha, Françoise Van Bambeke
Pharmacokinetics and pharmacological target attainment of standard temocillin dosing in non-critically ill patients with complicated urinary tract infections. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Frédéric Goormaghtigh, Françoise Van Bambeke
Understanding staphylococcus aureus internalization and induction of antimicrobial tolerance. Expert review of anti-infective therapy (2024)
Tamara V Milosevic, Gaëlle Vertenoeil, William Vainchenker, Paul M Tulkens, Stefan N Constantinescu, Françoise Van Bambeke
Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets. Antimicrobial agents and chemotherapy (2024)
Jean-Paul Pirnay, Françoise Van Bambeke, Christine Baysse, Miguel Cámara, Sylvie Chevalier, Jean François Collet, Aurélie Crabbé, Jozef Dingemans, Alain Dufour, Linda Eeckhaudt, Alain Filloux, Olivier Lesouhaitier, Qing Wei, Daniel De Vos
In memoriam: Pierre Cornelis (1949-2023). Journal of bacteriology (2024)
Françoise Van Bambeke, Sebastian Wicha, Paul M Tulkens, Markus Zeitlinger
Editorial for the Special Issue "A Themed Issue in Honor of Professor Hartmut Derendorf-Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology". Antibiotics (Basel, Switzerland) 12 (2) (2023)
Françoise Van Bambeke, Sebastian Wicha, Paul M Tulkens, Markus Zeitlinger
Editorial for the Special Issue "A Themed Issue in Honor of Professor Hartmut Derendorf-Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology". Antibiotics (Basel, Switzerland) 12 (2) (2023)
Steven De Soir, Hortence Parée, Nur Hidayatul Nazirah Kamarudin, Jeroen Wagemans, Rob Lavigne, Annabel Braem, Maya Merabishvili, Daniel De Vos, Jean-Paul Pirnay, Françoise Van Bambeke
Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections. Microbiology spectrum (2023)
Françoise Van Bambeke, Sebastian Wicha, Paul M Tulkens, Markus Zeitlinger
Editorial for the Special Issue "A Themed Issue in Honor of Professor Hartmut Derendorf-Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology". Antibiotics (Basel, Switzerland) 12 (2) (2023)
Perrin Ngougni Pokem, Xin Liu, Suzanne L Parker, Alexia Verroken, Christine Collienne, Patrice Finet, Gert-Jan Wijnant, Pierre-François Laterre, Jason Alexander Roberts, Françoise Van Bambeke, Xavier Wittebole
Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis. The Journal of antimicrobial chemotherapy (2023)
Angele Modupe Dohou, Valentina Oana Buda, Loconon Achille Yemoa, Severin Anagonou, Françoise Van Bambeke, Thierry Van Hees, Francis Moïse Dossou, Olivia Dalleur
Antibiotic Usage in Patients Having Undergone Caesarean Section: A Three-Level Study in Benin. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Angele Modupe Dohou, Valentina Oana Buda, Severin Anagonou, Françoise Van Bambeke, Thierry Van Hees, Francis Moïse Dossou, Olivia Dalleur
Healthcare Professionals' Knowledge and Beliefs on Antibiotic Prophylaxis in Cesarean Section: A Mixed-Methods Study in Benin. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Frédéric Peyrusson, Tiep Khac Nguyen, Tome Najdovski, Françoise Van Bambeke
Host Cell Oxidative Stress Induces Dormant Staphylococcus aureus Persisters. Microbiology spectrum 10 (1) (2022)
María Ángeles Meléndez-Carmona, Mikel Mancheño-Losa, Albert Ruiz-Sorribas, Irene Muñoz-Gallego, Esther Viedma, Fernando Chaves, Françoise Van Bambeke, Jaime Lora-Tamayo
Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin. The Journal of antimicrobial chemotherapy 77 (12) (2022)
Albert Ruiz, Hervé Poilvache, Nur Hidayatul Nazirah Kamarudin, Annabel Braem, Françoise Van Bambeke
Hydrolytic Enzymes as Potentiators of Antimicrobials against an Inter-Kingdom Biofilm Model. Microbiology spectrum 10 (1) (2022)
David De Bels, Evelyne Maillart, Françoise Van Bambeke, Sebastien Redant, Patrick M Honoré
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia. Expert opinion on emerging drugs (2022)
Albert Ruiz, Hervé Poilvache, Nur Hidayatul Nazirah Kamarudin, Annabel Braem, Françoise Van Bambeke
Correction for Ruiz-Sorribas et al., "Hydrolytic Enzymes as Potentiators of Antimicrobials against an Inter-Kingdom Biofilm Model". Microbiology spectrum (2022)
Frédéric Peyrusson, Tiep K Nguyen, Julien M Buyck, Sandrine Lemaire, Gang Wang, Cristina Seral, Paul M Tulkens, Françoise Van Bambeke
In Vitro Models for the Study of the Intracellular Activity of Antibiotics. Methods in molecular biology (Clifton, N.J.) 2357 (2022)
Albert Ruiz, Hervé Poilvache, Nur Hidayatul Nazirah Kamarudin, Annabel Braem, Françoise Van Bambeke
Correction for Ruiz-Sorribas et al., "Hydrolytic Enzymes as Potentiators of Antimicrobials against an Inter-Kingdom Biofilm Model". Microbiology spectrum 11 (1) (2022)
Perrin Ngougni Pokem, Peter Matzneller, Steven Vervaeke, Xavier Wittebole, Lieven Goeman, Marie Coessens, Eleonora Cottone, Arnaud Capron, Beatrix Wulkersdorfer, Pierre Wallemacq, Johan W Mouton, Anouk E Muller, Markus Zeitlinger, Pierre François Laterre, Paul M Tulkens, Françoise Van Bambeke
Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications. The Journal of antimicrobial chemotherapy 77 (10) (2022)
Gang Wang, Jean-Michel Brunel, Matthias Preusse, Negar Mozaheb, Sven D Willger, Gerald Larrouy-Maumus, Pieter Baatsen, Susanne Häußler, Jean Michel Bolla, Françoise Van Bambeke
The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence. Communications biology 5 (1) (2022)
Albert Ruiz, Hervé Poilvache, Nur Hidayatul Nazirah Kamarudin, Annabel Braem, Françoise Van Bambeke
Correction for Ruiz-Sorribas et al., "Hydrolytic Enzymes as Potentiators of Antimicrobials against an Inter-Kingdom Biofilm Model". Microbiology spectrum 11 (1) (2022)
Perrin Ngougni Pokem, Xavier Wittebole, Christine Collienne, Hector Rodriguez-Villalobos, Paul M Tulkens, Laure Elens, Françoise Van Bambeke, Pierre-François Laterre
Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Albert Ruiz, Hervé Poilvache, Françoise Van Bambeke
Pharmacodynamics of Moxifloxacin, Meropenem, Caspofungin, and Their Combinations against In Vitro Polymicrobial Interkingdom Biofilms. Antimicrobial agents and chemotherapy 66 (2) (2021)
Thu-Minh Nguyen, Thu-Hue Ngo, Truong Thanh Tuan, Dinh-Hoa Vu, Dinh-Chi Le, Ngan-Binh Vu, Tuyet-Nga Can, Nguyen Hoang Anh, Thu-Phuong Phan, Françoise Van Bambeke, Céline Vidaillac, Quy-Chau Ngo
Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Pharmaceutics 13 (4) (2021)
Hélène Thirot, Caroline Briquet, Frédéric Frippiat, Frédérique Jacobs, Xavier Holemans, Séverine Henrard, Paul M Tulkens, Anne Spinewine, Françoise Van Bambeke
Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers. Antibiotics (Basel, Switzerland) 10 (5) (2021)
Gang Wang, Jean-Michel Brunel, Jean-Michel Bolla, Françoise Van Bambeke
The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 65 (3) (2021)
Frédéric Peyrusson, Adam O Whelan, Margaret G Hartley, Isobel H Norville, Sarah V Harding, Françoise Van Bambeke
Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells. Antimicrobial agents and chemotherapy 65 (12) (2021)
Ivana Kerkez, Paul M Tulkens, Tanel Tenson, Françoise Van Bambeke, Marta Putrinš
Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an In Vitro Model of Intracellular Infection. Antimicrobial agents and chemotherapy 65 (12) (2021)
Hervé Poilvache, Albert Ruiz-Sorribas, Olivier Cornu, Françoise Van Bambeke
In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model. Antimicrobial agents and chemotherapy 65 (4) (2021)
Albert Ruiz, Hervé Poilvache, Nur Hidayatul Nazirah Kamarudin, Annabel Braem, Françoise Van Bambeke
In vitro polymicrobial inter-kingdom three-species biofilm model: influence of hyphae on biofilm formation and bacterial physiology. Biofouling 37 (5) (2021)
Yvan Diaz Iglesias, Françoise Van Bambeke
Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium. Antimicrobial agents and chemotherapy 64 (4) (2020)
Frédéric Peyrusson, Hugo Varet, Tiep Khac Nguyen, Rachel Legendre, Odile Sismeiro, Jean-Yves Coppée, Christiane Wolz, Tanel Tenson, Françoise Van Bambeke
Intracellular Staphylococcus aureus persisters upon antibiotic exposure. Nature communications 11 (1) (2020)
Milton Meerwein, Andrea Tarnutzer, Michelle Böni, Françoise Van Bambeke, Michael Hombach, Annelies S Zinkernagel
Increased Azithromycin Susceptibility of Multidrug-Resistant Gram-Negative Bacteria on RPMI-1640 Agar Assessed by Disk Diffusion Testing. Antibiotics (Basel, Switzerland) 9 (5) (2020)
Yvan Diaz Iglesias, Tobias Wilms, Rita Vanbever, Françoise Van Bambeke
Activity of Antibiotics against Staphylococcus aureus in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium. Antimicrobial agents and chemotherapy 63 (7) (2019)
Wafi Siala, Hector Rodriguez-Villalobos, Prabhavathi Fernandes, Paul M Tulkens, Françoise Van Bambeke
Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in In Vitro Static and Dynamic Models. Antimicrobial agents and chemotherapy 62 (7) (2018)
Frédéric Peyrusson, Paul M Tulkens, Françoise Van Bambeke
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells. Antimicrobial agents and chemotherapy 62 (4) (2018)
Tamara V Milosevic, Valéry L Payen, Pierre Sonveaux, Giulio G Muccioli, Paul M Tulkens, Françoise Van Bambeke
Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes. Antimicrobial agents and chemotherapy 62 (3) (2018)
Ahalieyah Anantharajah, Julien M Buyck, Charlotta Sundin, Paul M Tulkens, Marie-Paule Mingeot-Leclercq, Françoise Van Bambeke
Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms. Antimicrobial agents and chemotherapy 61 (6) (2017)
Lucy Catteau, Nathalie T Reichmann, Joshua Olson, Mariana G Pinho, Victor Nizet, Françoise Van Bambeke, Joëlle Quetin-Leclercq
Synergy between Ursolic and Oleanolic Acids from Vitellaria paradoxa Leaf Extract and β-Lactams against Methicillin-Resistant Staphylococcus aureus: In Vitro and In Vivo Activity and Underlying Mechanisms. Molecules (Basel, Switzerland) 22 (12) (2017)
Isabelle K Delattre, Fabio S Taccone, Frédérique Jacobs, Maya Hites, Thierry Dugernier, Herbert Spapen, Pierre-François Laterre, Pierre E Wallemacq, Françoise Van Bambeke, Paul M Tulkens
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective? Expert review of anti-infective therapy 15 (7) (2017)
Françoise Van Bambeke
Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review. Drugs 75 (18) (2016)
Muhammad-Hariri Mustafa, Hussein Chalhoub, Olivier Denis, Ariane Deplano, Anne Vergison, Hector Rodriguez-Villalobos, Michael M Tunney, J Stuart Elborn, Barbara C Kahl, Hamidou Traore, Francis Vanderbist, Paul M Tulkens, Françoise Van Bambeke
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe. Antimicrobial agents and chemotherapy 60 (11) (2016)
Frédéric Peyrusson, Deborah Butler, Paul M Tulkens, Françoise Van Bambeke
Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages. Antimicrobial agents and chemotherapy 59 (9) (2015)
Julien M Buyck, Frédéric Peyrusson, Paul M Tulkens, Françoise Van Bambeke
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria. Antimicrobial agents and chemotherapy 59 (8) (2015)

Françoise Van Bambeke.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Françoise Van Bambeke